Outpatient gatifloxacin therapy and dysglycemia in older adults.

Park-Wyllie, Laura Y., Juurlink, David N., Kopp, Alexander, Shah, Baiju R., Stukel, Therese A., Stumpo, Carmine, Dresser, Linda, Low, Donald E. +1 more·2006·New England Journal of Medicine
DOI 10.1056/nejmoa055191

Cited by (366)

Items 101–200 of 366

  1. Challenges in the development of drugs for the treatment of tuberculosis
    Adeeb Shehzad, Gauhar Rehman, Mazhar Ul‐Islam, Waleed Ahmad Khattak, Young Sup Lee · 2013 · The Brazilian Journal of Infectious Diseases
  2. Antimicrobials in urogenital infections
    Florian Wagenlehner, Björn Wullt, Gianpaolo Perletti · 2011 · International Journal of Antimicrobial Agents
  3. Ocular Infection: Endophthalmitis
    Stephen G. Schwartz, Harry W. Flynn, Taraprasad Das, William F. Mieler · 2015 · Developments in ophthalmology
  4. Bacterial Community-Acquired Pneumonia in Older Patients
    Gerald R. Donowitz, Heather L. Cox · 2007 · Clinics in Geriatric Medicine
  5. An investigation of the potential association between retinal detachment and oral fluoroquinolones: a self-controlled case series study
    Celine Sze Ling Chui, Kenneth K. C. Man, Ching‐Lan Cheng, Esther W. Chan, Wallis C. Y. Lau, Vincent Chi‐Chung Cheng, David Wong, Yea‐Huei Kao Yang, Ian Chi Kei Wong · 2014 · Journal of Antimicrobial Chemotherapy
  6. Short-Course Regimen for Multidrug-Resistant Tuberculosis: A Decade of Evidence
    Arnaud Trébucq, Tom Decroo, Armand Van Deun, Alberto Piubello, Chen‐Yuan Chiang, Kobto G. Koura, Valérie Schwoebel · 2019 · Journal of Clinical Medicine
  7. Phase I Trial of First-Line Bortezomib/Thalidomide plus Chemotherapy for Induction and Stem Cell Mobilization in Patients with Multiple Myeloma
    Ashraf Z. Badros, Olga G. Goloubeva, Robert G. Fenton, Aaron P. Rapoport, Görgün Akpek, Carolynn Harris, Kathleen Ruehle, Sandra Westphal, Barry R. Meisenberg · 2006 · Clinical Lymphoma & Myeloma
  8. Death following bilateral complete Achilles tendon rupture in a patient on fluoroquinolone therapy: a case report
    Andrew W. Gottschalk, John W. Bachman · 2009 · Journal of Medical Case Reports
  9. Gatifloxacin acutely stimulates insulin secretion and chronically suppresses insulin biosynthesis
    Chizumi Yamada, Kazuaki Nagashima, Akira Takahashi, Hiroyuki Ueno, Yukiko Kawasaki, Yuichiro Yamada, Yutaka Seino, Nobuya Inagaki · 2006 · European Journal of Pharmacology
  10. Statins and the Risk of Herpes Zoster: A Population-Based Cohort Study
    Tony Antoniou, Hong Yu Zheng, Samantha Singh, David Nelson Juurlink, Muhammad Mamdani, Tara Gomes · 2013 · Clinical Infectious Diseases
  11. Reappraisal of the treatment duration of antibiotic regimens for acute uncomplicated cystitis in adult women: a systematic review and network meta-analysis of 61 randomised clinical trials
    Do Kyung Kim, Jae Heon Kim, Joo Yong Lee, Nam Su Ku, Hye Sun Lee, Ju-Young Park, Jong Won Kim, Kwang Joon Kim, Kang Su Cho · 2020 · The Lancet Infectious Diseases
  12. A patient with type B insulin resistance syndrome, responsive to immune therapy
    Kathleen A. Page, Stephanie Déjardin, C. Ronald Kahn, Rohit Kulkarni, Kevan C. Herold, Silvio E. Inzucchi · 2007 · Nature Clinical Practice Endocrinology &#38 Metabolism
  13. Gatifloxacin-induced hyperglycemia: A case report and summary of the current literature
    Clifford Yip, Audrey J. Lee · 2006 · Clinical Therapeutics
  14. Road Trauma in Teenage Male Youth with Childhood Disruptive Behavior Disorders: A Population Based Analysis
    Redelmeier, Donald A., Chan, William K., Lu, Hong · 2010 · PLoS Medicine
  15. Sex differences in the outcomes of peripheral arterial disease: a population-based cohort study
    M. A. Hussain, Thomas F. Lindsay, Muhammad Mamdani, Xin Wang, Subodh Verma, Mohammed A. Al-Omran · 2016 · CMAJ Open
  16. New regimens for reducing the duration of treatment of drug‐susceptible pulmonary tuberculosis
    Marcus Barreto Conde, José Roberto Lapa e Silva · 2011 · Drug Development Research
  17. Ciprofloxacin-induced theophylline toxicity: a population-based study
    Tony Antoniou, Tara Gomes, Muhammad Mamdani, David Nelson Juurlink · 2011 · European Journal of Clinical Pharmacology
  18. Combined therapy for tuberculosis and HIV-1: the challenge for drug discovery
    Dominique J. Pepper, Graeme Meintjes, Helen McIlleron, Robert John Wilkinson · 2007 · Drug Discovery Today
  19. The insulinotropic effect of fluoroquinolones
    Hany Ghaly, Christine Kriete, Seher Sahin, Anja Pflöger, Ulrike Holzgrabe, Bernd J. Zünkler, Ingo Rustenbeck · 2008 · Biochemical Pharmacology
  20. Prescription Stimulant Use and Hospitalization for Psychosis or Mania: A Population-Based Study
    Cressman, Alex M., Macdonald, Erin M., Huang, Anjie, Gomes, Tara, Paterson, Michael J., Kurdyak, Paul A., Mamdani, Muhammad M., Juurlink, David N. · 2015 · Journal of Clinical Psychopharmacology
  21. Gatifloxacin Versus Ofloxacin for the Treatment of Uncomplicated Enteric Fever in Nepal: An Open-Label, Randomized, Controlled Trial
    Samir Koirala, Buddha Basnyat, Amit Arjyal, Olita Shilpakar, Kabina Shrestha, Rishav Shrestha, Upendra Man Shrestha, Krishna Agrawal, Kanika Deshpande Koirala, Sudeep Dhoj Thapa et al. · 2013 · PLoS neglected tropical diseases
  22. Pneumonia in the Older Patient
    Michael S. Niederman, Veronica Brito · 2007 · Clinics in Chest Medicine
  23. How Safe are Fluoroquinolones for Diabetic Patients? A Systematic Review of Dysglycemic and Neuropathic Effects of Fluoroquinolones
    Abdulrhman Althaqafi, Majid Ali, Yusuf Alzahrani, Long Chiau Ming, Zahid Hussain · 2021 · Therapeutics and Clinical Risk Management
  24. Update on the prevention and treatment of endophthalmitis
    Stephen G. Schwartz, Harry W. Flynn · 2014 · Expert Review of Ophthalmology
  25. Policy alternatives for treatments for rare diseases
    Abbas H. Panju, Chaim M. Bell · 2010 · Canadian Medical Association Journal
  26. Dysglycaemias and Fluoroquinolones
    Roshan J. Lewis, John Mohr · 2008 · Drug Safety
  27. Prevalence of extended spectrum beta-lactamase production among uropathogens in south Mumbai and its antibiogram pattern
    K. Aruna, Mobashshera, T. · 2012 · Europe PMC (PubMed Central)
  28. Towards new tuberculosis drugs
    Stewart Thomas Cole, Pedro M. Alzari · 2007 · Biochemical Society Transactions
  29. Validation of Carotid Artery Revascularization Coding in Ontario Health Administrative Databases
    Mohamad Anas Hussain, Muhammad Mamdani, Gustavo Saposnik, Jack V. Tu, David Turkel‐Parrella, Julian Spears, Mohammed A. Al-Omran · 2016 · Clinical and investigative medicine
  30. Safety of Delafloxacin: Focus on Adverse Events of Special Interest
    Thomas P. Lodise, Ralph G. Corey, David C. Hooper, Sue Cammarata · 2018 · Open Forum Infectious Diseases
  31. Medication-induced hyperglycemia and diabetes mellitus: a review of current literature and practical management strategies
    Jain, Akshay B., Lai, Valerie · 2024 · Diabetes Therapy
  32. Trimethoprim/sulfamethoxazole‐induced phenytoin toxicity in the elderly: a population‐based study
    Tony Antoniou, Tara Gomes, Muhammad Mamdani, David Nelson Juurlink · 2010 · British Journal of Clinical Pharmacology
  33. Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones inMycobacterium tuberculosis
    Nele Coeck, Bouke Catherine de Jong, Maren Diels, Pim de Rijk, Elisa Ardizzoni, Armand Van Deun, Leen Rigouts · 2016 · Journal of Antimicrobial Chemotherapy
  34. Impact of Unrestricted Access to Pregabalin on the Use of Opioids and Other CNS-Active Medications: A Cross-Sectional Time Series Analysis
    Herman Kwok, Wayne Khuu, Kimberly A. Fernandes, Diana Martins, Mina Tadrous, Samantha Singh, David Nelson Juurlink, Tara Gomes · 2016 · Pain Medicine
  35. The Safety of Proton Pump Inhibitors and Clopidogrel in Patients After Stroke
    David Nelson Juurlink, Tara Gomes, Muhammad Mamdani, David J. Gladstone, Moira K. Kapral · 2010 · Stroke
  36. Prevalence of and Risk Factors for Dysglycemia in Patients Receiving Gatifloxacin and Levofloxacin in an Outpatient Setting
    Kerry L. LaPlante, Tracey L. Mersfelder, Kristina E. Ward, Brian J. Quilliam · 2007 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  37. Postpartum maternal codeine therapy and the risk of adverse neonatal outcomes: A retrospective cohort study
    David Nelson Juurlink, Tara Gomes, Astrid Guttmann, Chelsea Hellings, Marco L.A. Sivilotti, Marie‐Andrée Harvey, Muhammad Mamdani · 2012 · Clinical Toxicology
  38. Medication‐induced diabetes mellitus
    David R. Repaske · 2016 · Pediatric Diabetes
  39. Projecting future drug expenditures—2007
    James M. Hoffman, Nilay D. Shah, Lee C. Vermeulen, Glen T. Schumock, Penny Grim, Robert J. Hunkler, Karrie M. Hontz · 2007 · American Journal of Health-System Pharmacy
  40. The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease
    Masaki Fujita, Hiroshi Ouchi, Eiji Harada, Satoshi Ikegame, Yoichi Nakanishi, Masaki Fujita, Takemasa Matsumoto, Junji Uchino, Kentaro Watanabe, Akira Kajiki et al. · 2011 · Journal of Infection and Chemotherapy
  41. Effect of levofloxacin on serum glucose concentration in rats
    Yasuyoshi Ishiwata, Yoshie Itoga, Masato Yasuhara · 2006 · European Journal of Pharmacology
  42. Effects of Gatifloxacin and Levofloxacin on Rates of Hypoglycemia and Hyperglycemia Among Elderly Hospitalized Patients
    Thomas P. Lodise, Jeffrey P. Graves, Chris Miller, John Mohr, Ben M. Lomaestro, Raymond P. Smith · 2007 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  43. Gatifloxacin is superior to levofloxacin and moxifloxacin in shorter treatment regimens for multidrug-resistant TB
    Armand Van Deun, Tom Decroo, Christopher Kuaban, J Noeske, Alberto Piubello, K. J. M. Aung, Hans L. Rieder · 2019 · The International Journal of Tuberculosis and Lung Disease
  44. QT prolongation in the intensive care unit: commonly used medications and the impact of drug–drug interactions
    Pamela L. Smithburger, Amy L. Seybert, Michael J. Armahizer, Sandra L. Kane‐Gill · 2010 · Expert Opinion on Drug Safety
  45. Dysglycemia associated with quinolones
    Sara El Ghandour, Sami T. Azar · 2014 · Primary care diabetes
  46. Studying new antibiotics for multidrug resistant infections: are today’s patients paying for unproved future benefits?
    John H. Powers, Scott R. Evans, Aaron Seth Kesselheim · 2018 · BMJ
  47. Levofloxacin‐associated hypoglycaemia complicated by pontine myelinolysis and quadriplegia
    Srikanth Vallurupalli, Graham Huesmann, J. Gregory, Michael Jakoby · 2008 · Diabetic Medicine
  48. Drug-versus-Drug Adverse Event Rate Comparisons
    Alan M. Hochberg, Ronald K. Pearson, Donald J. O’Hara, Stephanie J. Reisinger · 2009 · Drug Safety
  49. Use of Pharmacodynamic Principles to Optimise Dosage Regimens for Antibacterial Agents in the Elderly
    Ayman M. Noreddin, Virginia L. Haynes · 2007 · Drugs & Aging
  50. Hypoglycemia associated with the use of levofloxacin
    Seth M. Garber, Melanie W. Pound, Susan M. Miller · 2009 · American Journal of Health-System Pharmacy
  51. Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high‐risk population
    David Nelson Juurlink, Tara Gomes, Baiju R. Shah, Muhammad Mamdani · 2012 · Diabetic Medicine
  52. A study on drug safety monitoring program in India.
    Akram Ahmad, Isha Patel, Sudeepa Sanyal, Rajesh Balkrishnan, GP Mohanta · 2014 · Europe PMC (PubMed Central)
  53. A Simple Text Mining Approach for Ranking Pairwise Associations in Biomedical Applications
    Finn Kuusisto, John Steill, Zhaobin Kuang, James Alexander Thomson, Page, David, Ron M. Stewart · 2019 · PubMed Central
  54. Moxifloxacin in the treatment of skin and skin structure infections
    David R.P. Guay · 2006 · Therapeutics and Clinical Risk Management
  55. Serious Adverse Drug Effects — Seeing the Trees through the Forest
    Jerry H. Gurwitz · 2006 · New England Journal of Medicine
  56. Gatifloxacin Pharmacokinetics/Pharmacodynamics–based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis
    Devyani Deshpande, Jotam G. Pasipanodya, Shashikant Srivastava, Paula Bendet, Thearith Koeuth, Sujata M. Bhavnani, Paul G. Ambrose, Wynand A. Smythe, Helen McIlleron, Guy Edward Thwaites et al. · 2018 · Clinical Infectious Diseases
  57. Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis
    Francis S. Mah, Cervantes · 2011 · Clinical ophthalmology
  58. The management of antimicrobial-resistant enteric fever
    Christopher Mark Parry, Buddha Basnyat, John A. Crump · 2013 · Expert Review of Anti-infective Therapy
  59. A Multi-Center Randomized Trial to Assess the Efficacy of Gatifloxacin versus Ciprofloxacin for the Treatment of Shigellosis in Vietnamese Children
    Ha Vinh, Vo Thi Cuc Anh, Nguyễn Đức Anh, James I. Campbell, Nguyễn Văn Minh Hoàng, Tran Vu Thieu Nga, Nguyen Thi Khanh Nhu, Pham Van Minh, Cao Thu Thuy, Duy Pham Thanh et al. · 2011 · PLoS neglected tropical diseases
  60. Oral gatifloxacin in the outpatient treatment of children with cancer fever and neutropenia
    AntonioSérgio Petrilli, Fabianne Altruda de Moraes Costa Carlesse, Carlos Alberto Pires Pereira · 2007 · Pediatric Blood & Cancer
  61. Effects of fluoroquinolones on HERG channels and on pancreatic β-cell ATP-sensitive K+ channels
    Bernd J. Zünkler, Sonja Claaßen, Maria Wos-Maganga, Ingo Rustenbeck, Ulrike Holzgrabe · 2006 · Toxicology
  62. Commentary: Co-occurrence of tuberculosis and diabetes: new paradigm of epidemiological transition
    Matthew James Magee, Henry M. Blumberg, K.M. Venkat Narayan · 2011 · International Journal of Epidemiology
  63. Decision support during electronic prescription to stem antibiotic overuse for acute respiratory infections: a long-term, quasi-experimental study
    Jeneen M. Gifford, Elisabeth Vaeth, Katherine Richards, Tariq Siddiqui, Christine Gill, Lucy E Wilson, Sylvain DeLisle · 2017 · BMC Infectious Diseases
  64. Antituberculosis therapy for 2012 and beyond
    Michael Lauzardo, Charles A. Peloquin · 2012 · Expert Opinion on Pharmacotherapy
  65. Aspiration Pneumonia
    Rakan Nasreddine, Nicolás Dauby · 2019 · New England Journal of Medicine
  66. Gatifloxacin Ophthalmic Solution for Treatment of Bacterial Conjunctivitis: Safety, Efficacy and Patient Perspective
    Clyde L Schultz · 2012 · Ophthalmology and Eye Diseases
  67. Twenty‐six years of enteric fever in Australia: an epidemiological analysis of antibiotic resistance
    Robert J. Commons, Emma Sue McBryde, Mary Valcanis, Joan Powling, Alan Street, Geoff G. Hogg · 2012 · The Medical Journal of Australia
  68. Linezolid-Associated Hypoglycemia in a 64-Year-Old Man With Type 2 Diabetes
    Timothy W. Bodnar, Katelyn Starr, Jeffrey B. Halter · 2011 · The American Journal of Geriatric Pharmacotherapy
  69. Ciprofloxacin and risk of hypoglycemia in non-diabetic patients
    Abiel Berhe, Mulugeta Russom, Fithawit Bahran Gebreigziabher, Goitom Hagos · 2019 · Journal of Medical Case Reports
  70. Liver and Pancreas
    Peter Greaves · 2007 · Elsevier eBooks
  71. No Increase in Adverse Events During Aliskiren Use Among Ontario Patients Receiving Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers
    Cameron J. Gilbert, Tara Gomes, Muhammad Mamdani, Chelsea Hellings, Zhan Yao, Amit X. Garg, Ron Wald, Ziv Harel, David Nelson Juurlink · 2013 · Canadian Journal of Cardiology
  72. Comparison of the adverse event profiles of levofloxacin 500 mg and 750 mg in clinical trials for the treatment of respiratory infections
    Mohammed M. Khashab, Jim X. Xiang, James B. Kahn · 2006 · Current Medical Research and Opinion
  73. Comparative effectiveness of angiotensin-receptor blockers for preventing macrovascular disease in patients with diabetes: a population-based cohort study
    Tony Antoniou, Ximena Camacho, Zhan Yao, Tara Gomes, David Nelson Juurlink, Muhammad Mamdani · 2013 · Canadian Medical Association Journal
  74. Gatifloxacin Induces Augmented Insulin Release and Intracellular Insulin Depletion of Pancreatic Islet Cells
    Takashi Tomita, Mariko Onishi, Eiji Sato, Yasuhiro Kimura, Kenji Kihira · 2007 · Biological and Pharmaceutical Bulletin
  75. Drug-induced hyperglycemia and diabetes
    Marie-Anne Heurtebize, Jean‐Luc Faillie · 2023 · Therapies
  76. A complex suite of loci and elements in eukaryotic type II topoisomerases determine selective sensitivity to distinct poisoning agents
    Tim R. Blower, Afif F. Bandak, Amy S.Y. Lee, Caroline A. Austin, John L. Nitiss, James M. Berger · 2019 · Nucleic Acids Research
  77. Treatment of Enteric Fever
    Anil Pandit, Amit Arjyal · 2008 · The Journal of Infection in Developing Countries
  78. Gatifloxacin-induced dysglycemia
    Rosemary K Zvonar · 2006 · American Journal of Health-System Pharmacy
  79. A Population-Based Assessment of the Drug Interaction Between Levothyroxine and Warfarin
    Pincus, D, Gomes, T, Hellings, C, Zheng, H, Paterson, J M, Mamdani, M M, Juurlink, D N · 2012 · Clinical Pharmacology & Therapeutics
  80. Validation of a Modified Version of the National Nosocomial Infections Surveillance System Risk Index for Health Services Research
    Nick Daneman, Andrew E. Simor, Donald A. Redelmeier · 2009 · Infection Control and Hospital Epidemiology
  81. A Moxifloxacin-based Regimen for the Treatment of Recurrent, Drug-sensitive Pulmonary Tuberculosis: An Open-label, Randomized, Controlled Trial
    Rubeshan Perumal, Nesri Padayatchi, Nonhlanhla Yende‐Zuma, Anushka Naidoo, Dhineshree Govender, Kogieleum Naidoo · 2019 · Clinical Infectious Diseases
  82. Effect of fluoroquinolones on mitochondrial function in pancreatic beta cells
    Hany Ghaly, Anne Jörns, Ingo Rustenbeck · 2013 · European Journal of Pharmaceutical Sciences
  83. Gatifloxacin affects GLUT1 gene expression and disturbs glucose homeostasis in vitro
    Tian-Fang Ge, Pui Ying Peggy Law, Hei Yi Wong, Yuan-Yuan Ho · 2007 · European Journal of Pharmacology
  84. Drug-Resistant Tuberculosis
    Amr S. Albanna, Dick Menzies · 2011 · Drugs
  85. A population‐based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors
    Alex M. Cressman, Erin M. Macdonald, Kimberly A. Fernandes, Tara Gomes, John Michael Paterson, Muhammad Mamdani, David Nelson Juurlink · 2015 · British Journal of Clinical Pharmacology
  86. Hypoglycemia - Causes and Occurrences
    Cid Rigobelo, Everlon · 2011 · InTech eBooks
  87. Interactions between antiretroviral agents and those used to treat tuberculosis
    Stefano Bonora, Giovanni Di Perri · 2008 · Current Opinion in HIV and AIDS
  88. The treatment of enteric fever
    Buddha Basnyat · 2007 · Journal of the Royal Society of Medicine
  89. Effects of Funding Policy Changes and Health Warnings on the Use of Erythropoiesis-Stimulating Agents
    Matthew A. Weir, Tara Gomes, Eric Winquist, David Nelson Juurlink, Meaghan S. Cuerden, Muhammad Mamdani · 2012 · Journal of Oncology Practice
  90. Treatment of multidrug-resistant and extensively drug-resistant tuberculosis: current status and future prospects
    Cheuk Ming Tam, Wing-Wai Yew, Kwok‐Yung Yuen · 2009 · Expert Review of Clinical Pharmacology
  91. Evaluation of Initial and Steady-State Gatifloxacin Pharmacokinetics and Dose in Pulmonary Tuberculosis Patients by Using Monte Carlo Simulations
    Wynand A. Smythe, Corinne Simone Merle, Roxana Rustomjee, Martin Gninafon, Mame Bocar Lo, Oumou Younoussa Bah-Sow, Piero Olliaro, Christian Lienhardt, John D. Horton, Peter John Smith et al. · 2013 · Antimicrobial Agents and Chemotherapy
  92. Identifying geographical regions serviced by hospitals to assess laboratory-based outcomes
    Sonja Gandhi, Salimah Z. Shariff, Michael M. Beyea, Matthew A. Weir, Theresa Hands, Glen Kearns, Amit X. Garg · 2013 · BMJ Open
  93. Gatifloxacin-induced histamine release and hyperglycemia in rats
    Yasuyoshi Ishiwata, Masato Yasuhara · 2010 · European Journal of Pharmacology
  94. Gatifloxacin Produces Both Hypoglycemia and Hyperglycemia: A Retrospective Study
    Solomon S. Solomon, Haleh Haerian, Peter Mchugh, Grant W. Somes, Richard Brown · 2008 · The American Journal of the Medical Sciences
  95. Quinolone Antibacterial Agents
    Rosaleen J. Anderson, Paul W. Groundwater, Adam Todd, Alan J. Worsley · 2012
  96. Gatifloxacin and Dysglycemia in Older Adults
    Vijay Yadav, Kuldeep Deopujari · 2006 · New England Journal of Medicine
  97. Comparative risk of serious hypoglycemia among persons dispensed a fluoroquinolone versus a non-fluoroquinolone antibiotic
    Darcy E. Ellis, Rebecca A. Hubbard, Allison Wright Willis, Athena F. Zuppa, Theoklis E. Zaoutis, Sean Hennessy · 2022 · Diabetes Research and Clinical Practice
  98. Current therapies for the treatment of multidrug-resistant tuberculosis in children in India
    Aparna Mukherjee, Rakesh Lodha, Sushil Kumar Kabra · 2017 · Expert Opinion on Pharmacotherapy
  99. People with diabetes should avoid antibiotic gatifloxacin
    Claire Kendall · 2006 · Canadian Medical Association Journal
  100. Management of Tuberculosis in Children and New Treatment Options
    Ben J. Marais, Hendrik Simon Schaaf, Peter Roderick Donald · 2011 · Infectious Disorders - Drug Targets